Question 1

Does Ubs own GLPG stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 168,148 shares of GLPG (Lakefront Biotherapeutics), worth $5M.

Question 2

How many shares of GLPG does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 168,148 shares of GLPG (Lakefront Biotherapeutics).

Question 3

What is Ubs' GLPG position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' GLPG position is worth $5M.

Question 4

Is Ubs buying or selling GLPG?

Accepted Answer

In Q2 2026, Ubs reduced its GLPG position by 7,141 shares (-4.1%).

Question 5

When did Ubs first buy GLPG?

Accepted Answer

Ubs already held GLPG in its Q1 2019 13F, the earliest on record, and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	168,148	-4.1%	$5M	0.0%	$27.73	0
2026-Q1	Decreased	175,289	-49.8%	$5.3M	0.0%	$33.05	0
2025-Q4	Increased	349,444	+128.4%	$11.4M	0.0%	$32.61	45
2025-Q3	Decreased	152,999	-35.9%	$5.3M	0.0%	$34.43	0
2025-Q2	Increased	238,524	+118.8%	$6.7M	0.0%	$27.98	44
2025-Q1	Increased	109,011	+44.2%	$2.7M	0.0%	$25.46	35
2024-Q4	Increased	75,579	+7596.4%	$2.1M	0.0%	$27.30	42
2024-Q3	Decreased	982	-7.0%	$28,272	0.0%	$29.28	0

GLPGShowing 8 of 30 quarters

GLPG
Showing 8 of 30 quarters